Study on the Intervention of Mindfulness-integrated Volleyball Course

June 30, 2025 updated by: Ye Zhiyin

The purpose of this clinical trial is to understand whether a mindfulness-integrated volleyball team sports program can effectively intervene in the mental health of college students, and whether it has better intervention effects compared to a regular volleyball team sports program. The main questions it aims to answer are:

Does the mindfulness-integrated volleyball team sports program effectively intervene in the participants' mental health levels, including indicators such as anxiety and depression? The researchers will compare the mindfulness-integrated volleyball team sports program with the regular volleyball team sports program to see if the intervention effects are more effective.

Participants will:

Attend a mindfulness-integrated volleyball team sports program once a week for 2 hours each session, for a total of 16 weeks.

Complete a psychological questionnaire at the beginning and the end of the program concludes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study will focus on a non-clinical population of college students, using an exploratory parallel randomized controlled trial design. Based on the inclusion criteria, participants will be allocated to the experimental group and control group according to their registration time. The experimental group will receive the mindfulness-integrated volleyball program, while the control group will participate in a regular volleyball program. The intervention will last for a total of 16 weeks, with sessions held once a week for 120 minutes each. Relevant assessments will be conducted at two time points: on the day before the intervention, and on the last day of the intervention.

Primary indicators: Youth version of the Patient Health Questionnaire, Generalized Anxiety Disorder Scale.

Secondary indicators: Insomnia Severity Index, Self-Efficacy Scale, Positive and Negative Affect Scale, Life Satisfaction Scale, Self-Esteem Scale, Self-Compassion Scale, Loneliness Scale, Social Anxiety Scale, Perceived Social Support Scale.

All of the above indicators will be measured using the corresponding questionnaires at two time points: T1 pre-test (before the start), T2 after 16 weeks of intervention, for a total of two assessments.

Inclusion criteria: (1) Participants aged ≥16 years; (2) Able to communicate in Mandarin and willing to voluntarily participate in this study; (3) Agree to consistently attend each mindfulness-integrated volleyball session.

Exclusion criteria: (1) Individuals with language communication barriers or unwilling to cooperate in this study; (2) Individuals unable to commit to attending each mindfulness-integrated volleyball session.

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China, 100875
        • Central University of Finance and Economics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants aged 16 years or older.
  • Able to communicate in Mandarin and voluntarily participate in the study.
  • Agree to consistently participate in each mindfulness-integrated volleyball course.

Exclusion Criteria:

  • Disagree to consistently participate in each mindfulness-integrated volleyball course.
  • Individuals unable to commit to participating in each mindfulness-integrated volleyball course.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Conduct approximately 10 minutes of mindful walking after the 110-minute regular physical education group class.
Behavioral: Mindful Walking meditation
Conduct approximately 10 minutes of mindful walking after the 110-minute regular physical education group class.
Active Comparator: Control group
120 minutes regular physical education group class.
Behavioral: physical education group class
120 minutes physical education group class about volleyball.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
depression
Time Frame: From enrollment to the end of treatment at 16 weeks
Using GAD-7 to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
anxiety
Time Frame: From enrollment to the end of treatment at 16 weeks
Using PHQ-9 to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2 (after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
social anxiety
Time Frame: From enrollment to the end of treatment at 16 weeks
Using Mini-SPIN to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
insomnia
Time Frame: From enrollment to the end of treatment at 16 weeks
Using ISI-7 to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
positive and negative affects
Time Frame: From enrollment to the end of treatment at 16 weeks
Using PANAS to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
life satisfaction
Time Frame: From enrollment to the end of treatment at 16 weeks
Using SWLS to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self-esteem
Time Frame: From enrollment to the end of treatment at 16 weeks
Using WFI to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
self-efficacy
Time Frame: From enrollment to the end of treatment at 16 weeks
Using GSES to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
self compassion
Time Frame: From enrollment to the end of treatment at 16 weeks
Using SCS-SF to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
loneliness
Time Frame: From enrollment to the end of treatment at 16 weeks
Using Revised ULS-3 to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks
perceived support
Time Frame: From enrollment to the end of treatment at 16 weeks
Using BPSSQ to investigate the psychological variables of participants, a total of two assessments will be conducted, including T1 pre-test (before the start) and T2(after 16 weeks of intervention).
From enrollment to the end of treatment at 16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ye Zhiyin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2024

Primary Completion (Actual)

March 2, 2025

Study Completion (Actual)

March 2, 2025

Study Registration Dates

First Submitted

September 13, 2024

First Submitted That Met QC Criteria

September 13, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

July 3, 2025

Last Update Submitted That Met QC Criteria

June 30, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CUFinanceEcon

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe